You might also be interested by
CellTalk Blog
Tregs in Focus: How a Nobel-Winning Finding is Shaping Clinical Research
October 22, 2025
More infoScientific Publications
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors
October 20, 2025
More infoPress Releases
Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials
September 24, 2025
More info